141 related articles for article (PubMed ID: 34241947)
1. Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.
Eberli FR; Stoll HP; Urban P; Morice MC; Brunel P; Maillard L; Lipiecki J; Cook S; Berland J; Hovasse T; Carrie D; Schütte D; Slama SS; Garot P
Catheter Cardiovasc Interv; 2022 Feb; 99(3):593-600. PubMed ID: 34241947
[TBL] [Abstract][Full Text] [Related]
2. Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes.
Menown IBA; Mamas MA; Cotton JM; Hildick-Smith D; Eberli FR; Leibundgut G; Tresukosol D; Macaya C; Copt S; Slama SS; Oldroyd KG
J Interv Cardiol; 2021; 2021():6654515. PubMed ID: 33880087
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes with thin versus thick strut polymer-free biolimus-coated stents at 3 years.
Eberli FR; Oldroyd KG; Urban P; Krucoff MW; Morice MC; Tanguay JF; Leon MB; Brunel P; Maillard L; Lipiecki J; Cook S; Berland J; Hovasse T; Carrié D; Schütte D; Sadozai Slama S; Garot P
Open Heart; 2024 Jun; 11(1):. PubMed ID: 38890129
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation Substudy.
Carrié D; Menown I; Oldroyd K; Copt S; Talwar S; Maillard L; Morice MC; Teik LS; Lang I; Urban P
JACC Cardiovasc Interv; 2017 Aug; 10(16):1633-1642. PubMed ID: 28838473
[TBL] [Abstract][Full Text] [Related]
5. Comparison of outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The BioFreedom France study.
Garot P; Brunel P; Dibie A; Morelle JF; Abdellaoui M; Levy R; Carrié D; Karsenty B; Robin C; Berland J; Copt S; Sadozai Slama S; Oldroyd K; Morice MC; Lipiecki J;
Catheter Cardiovasc Interv; 2023 Jan; 101(1):60-71. PubMed ID: 36378683
[TBL] [Abstract][Full Text] [Related]
6. Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II Study.
Krucoff MW; Urban P; Tanguay JF; McAndrew T; Zhang Y; Rao SV; Morice MC; Price MJ; Cohen DJ; Abdel-Wahab M; Mehta SR; Faurie B; McLaurin B; Diaz C; Stoll HP; Pocock S; Leon MB
Circ Cardiovasc Interv; 2020 Apr; 13(4):e008603. PubMed ID: 32279567
[TBL] [Abstract][Full Text] [Related]
7. Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial.
Sabaté M; Okkels Jensen L; Tilsted HH; Moreno R; García Del Blanco B; Macaya C; Pérez de Prado A; Cequier À; Pérez-Fuentes P; Schütte D; Costa RA; Stoll HP; Flensted Lassen J
EuroIntervention; 2021 Jun; 17(3):233-239. PubMed ID: 33433389
[TBL] [Abstract][Full Text] [Related]
8. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
9. Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE.
Windecker S; Latib A; Kedhi E; Kirtane AJ; Kandzari DE; Mehran R; Price MJ; Abizaid A; Simon DI; Worthley SG; Zaman A; Hudec M; Poliacikova P; Kahar Bin Abdul Ghapar A; Selvaraj K; Petrov I; Mylotte D; Pinar E; Moreno R; Fabbiocchi F; Pasupati S; Kim HS; Aminian A; Tie C; Wlodarczak A; Hur SH; Marx SO; Ali ZA; Parke M; Lung TH; Stone GW;
JACC Cardiovasc Interv; 2022 Jun; 15(11):1153-1163. PubMed ID: 35680195
[TBL] [Abstract][Full Text] [Related]
10. High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.
Zocca P; Kok MM; van der Heijden LC; Danse PW; Schotborgh CE; Scholte M; Hartmann M; Linssen GCM; Doggen CJM; von Birgelen C
Cardiovasc Drugs Ther; 2018 Dec; 32(6):567-576. PubMed ID: 30143879
[TBL] [Abstract][Full Text] [Related]
11. Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients.
Marquis-Gravel G; Urban P; Copt S; Capodanno D; Pocock SJ; Sadozai Slama S; Stoll HP; Tanguay JF; Mehran R; Leon MB; Rao SV; Morice MC; Krucoff MW
EuroIntervention; 2021 Jun; 17(3):240-247. PubMed ID: 32830645
[TBL] [Abstract][Full Text] [Related]
12. Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.
Jensen LO; Thayssen P; Maeng M; Ravkilde J; Krusell LR; Raungaard B; Junker A; Terkelsen CJ; Veien KT; Villadsen AB; Kaltoft A; Tilsted HH; Hansen KN; Aaroe J; Kristensen SD; Hansen HS; Jensen SE; Madsen M; Bøtker HE; Berencsi K; Lassen JF; Christiansen EH
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412869
[TBL] [Abstract][Full Text] [Related]
13. 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.
Garot P; Morice MC; Tresukosol D; Pocock SJ; Meredith IT; Abizaid A; Carrié D; Naber C; Iñiguez A; Talwar S; Menown IBA; Christiansen EH; Gregson J; Copt S; Hovasse T; Lurz P; Maillard L; Krackhardt F; Ong P; Byrne J; Redwood S; Windhövel U; Greene S; Stoll HP; Urban P;
J Am Coll Cardiol; 2017 Jan; 69(2):162-171. PubMed ID: 27806919
[TBL] [Abstract][Full Text] [Related]
14. Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.
Buiten RA; Ploumen EH; Zocca P; Doggen CJM; Danse PW; Schotborgh CE; Scholte M; van Houwelingen KG; Stoel MG; Hartmann M; Tjon Joe Gin RM; Somi S; Linssen GCM; Kok MM; von Birgelen C
JACC Cardiovasc Interv; 2019 Sep; 12(17):1650-1660. PubMed ID: 31422087
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimus-eluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR Registry.
Leistner DM; Rampat R; Haude M; Schmitz T; Allali A; Möllmann H; Stähli BE; Rudolph TK; Lauten A; Koning R; Bogaerts K; Sudhir K; Naber C
Minerva Cardiol Angiol; 2024 Aug; 72(4):355-365. PubMed ID: 38804621
[TBL] [Abstract][Full Text] [Related]
16. Polymer-free drug-coated coronary stents in diabetic patients at high bleeding risk: a pre-specified sub-study of the LEADERS FREE trial.
Richardt G; Maillard L; Nazzaro MS; Abdel-Wahab M; Carrié D; Iñiguez A; Garot P; Abdellaoui M; Morice MC; Foley D; Copt S; Stoll HP; Urban P
Clin Res Cardiol; 2019 Jan; 108(1):31-38. PubMed ID: 29951803
[TBL] [Abstract][Full Text] [Related]
17. Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials.
Hansen KW; Jeger R; Sørensen R; Kaiser C; Pfisterer M; Biering-Sørensen T; Bjerking LH; Galatius S
BMC Cardiovasc Disord; 2019 Oct; 19(1):226. PubMed ID: 31619181
[TBL] [Abstract][Full Text] [Related]
18. Twelve-month outcomes of patients unsuitable for prolonged DAPT presenting with an acute coronary syndrome and treated with polymer-free biolimus A9 drug-coated stents.
Kinnaird T; Abdul F; Hailan A; Sheikh A; Hinton J; Yazji K; Elangovan S; Yousef A; Gallagher S; Choudhury A; Anderson R; O'Kane P; Smith D
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1220-1228. PubMed ID: 30244504
[TBL] [Abstract][Full Text] [Related]
19. 1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
Chandrasekhar J; Kok MM; Kalkman DN; Aquino MB; Zocca P; Woudstra P; Beijk MA; Kerkmeijer LS; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Pocock S; von Birgelen C; Mehran R; de Winter RJ;
JACC Cardiovasc Interv; 2020 Apr; 13(7):820-830. PubMed ID: 32273094
[TBL] [Abstract][Full Text] [Related]
20. Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial.
Jensen Lisette Okkels; Maeng M; Raungaard B; Kahlert J; Ellert J; Jakobsen L; Villadsen AB; Veien KT; Kristensen SD; Ahlehoff O; Carstensen S; Christensen MK; Terkelsen CJ; Engstroem T; Hansen KN; Bøtker HE; Aaroe J; Thim T; Thuesen L; Freeman P; Aziz A; Eftekhari A; Junker A; Jensen SE; Lassen JF; Hansen HS; Christiansen EH;
Circulation; 2020 Jun; 141(25):2052-2063. PubMed ID: 32434381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
